Actinic Keratosis
📧 Sign up to get email alerts when something new happens for Actinic Keratosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Pharmacokinetics of Ingenol Mebutate Gel in Actinic Keratosis Under Maximum Use Conditions [Phase 1]
Phase 1 pharmacokinetic study evaluating Ingenol Mebutate Gel in actinic keratosis under maximum use conditions.
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Pharmacokinetics of LEO 43204 Gel in Actinic Keratosis Administered Under Maximal Use Conditions [Phase 1]
A Phase 1 pharmacokinetic study of LEO 43204 Gel in actinic keratosis under maximal-use conditions has completed, reporting PK data.
-
CLINICAL_TRIALS trial_result · 2025-02-20Clinical Trial Update: A Study of Tirbanibulin on the Wellbeing of Participants With Actinic Keratoses [Phase 4]
A Phase 4 study evaluating tirbanibulin for actinic keratosis has completed. Results from the trial have been posted.
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: A Study of Tirbanibulin Ointment and Diclofenac Sodium Gel for the Treatment of Adult Participants With Actinic Keratosis on the Face or Scalp [Phase 4]
Phase 4 clinical trial evaluating the combination of tirbanibulin ointment and diclofenac sodium gel for actinic keratosis on the face or sc…
-
CLINICAL_TRIALS research · 2025-01-31Clinical Trial Update: Photodynamic Therapy Incubation Times for Actinic Keratosis [NA]
A Northwestern University trial studying photodynamic therapy incubation times for actinic keratosis is currently active but not recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: Incidence of Melanoma and Non-melanoma Skin Cancer in People With Vitiligo
This completed clinical trial update examines the incidence of melanoma and non-melanoma skin cancers in people with vitiligo, with results …
-
CLINICAL_TRIALS research · 2024-12-24Clinical Trial Update: Cryotherapy in Combination with Red Light PDT for Actinic Keratosis of Full Face [Phase 4]
Phase 4 clinical trial update on using cryotherapy in combination with red light photodynamic therapy for actinic keratosis on the full face…
-
CLINICAL_TRIALS trial_result · 2024-12-19Clinical Trial Update: Photodynamic Therapy-Induced Immune Modulation: Part III [Phase 1]
Phase 1 trial investigating photodynamic therapy-induced immune modulation for actinic keratosis was terminated, with results posted in Dece…
-
CLINICAL_TRIALS research · 2024-11-12Clinical Trial Update: Efficacy of Topical 5-Fluorouracil Vs Calcipotriol As Photodynamic Therapy Pre-treatment for Field Actinic Keratoses [NA]
A clinical trial compares topical 5-fluorouracil and calcipotriol as pre-treatment before photodynamic therapy for actinic keratosis, with t…
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: Comparing Immune Responses to Topical Imiquimod
A terminated clinical trial comparing immune responses to topical Imiquimod in actinic keratosis patients has ended.
-
CLINICAL_TRIALS trial_result · 2024-10-17Clinical Trial Update: Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp [Phase 1]
Phase 1 study evaluating safety and tolerability of BF-200 ALA (Ameluz) for photodynamic therapy in the expanded field of actinic keratosis …
-
FDA approval · 2024-10-04FDA Approved: AMELUZ — Supplemental Application (Biofrontera Inc.)
FDA approved a supplemental application for AMELUZ (aminolevulinic acid hydrochloride) from Biofrontera Inc. The action involves changes to …
-
CLINICAL_TRIALS trial_result · 2024-09-20Clinical Trial Update: Patient and Clinician Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis
A completed clinical trial update reports patient- and clinician-reported outcomes on the effectiveness and safety of tirbanibulin for actin…
-
FDA approval · 2024-09-16FDA Approved: ZYCLARA — Supplemental Application (Bausch Health US, LLC)
FDA approved a supplemental application for ZYCLARA (imiquimod) filed by Bausch Health US, LLC.
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: Efficacy And Safety Of Illumination Dose Reduction In Red Light Photodynamic Therapy For Actinic Keratoses [NA]
Clinical trial update on reducing illumination dose in red-light photodynamic therapy for actinic keratosis to evaluate efficacy and safety.
-
CLINICAL_TRIALS research · 2024-08-06Clinical Trial Update: Microwave Treatment for Actinic Keratosis [NA]
This clinical trial update shows an active-not-recruiting study evaluating microwave treatment for actinic keratosis.
-
CLINICAL_TRIALS trial_result · 2024-07-26Clinical Trial Update: Duration of Ameluz Application in Acral Actinic Keratoses Response [Phase 4]
A Phase 4 clinical trial update notes the termination of a study evaluating the optimal duration of Ameluz application for acral actinic ker…
-
CLINICAL_TRIALS research · 2024-07-24Clinical Trial Update: The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population [NA]
A clinical trial is investigating whether fractionated laser resurfacing can prevent actinic neoplasia in at-risk older adults, including ac…
-
CLINICAL_TRIALS trial_result · 2024-06-27Clinical Trial Update: Study of Daylight Photodynamic Therapy With Aminolevulinic Acid for Actinic Keratoses [Phase 4]
Phase 4 clinical trial update evaluating daylight photodynamic therapy with aminolevulinic acid for actinic keratosis; results have been pos…
-
FDA approval · 2024-06-07FDA Approved: KLISYRI — Supplemental Application (Almirall, LLC)
The FDA approved a supplemental application for KLISYRI (tirbanibulin) by Almirall, LLC. This action pertains to the approved NDA 213189.
-
CLINICAL_TRIALS withdrawal · 2024-05-30Clinical Trial Update: Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis on the Back of the Hands [Phase 4]
Phase 4 clinical trial evaluating tirbanibulin 1% ointment for actinic keratosis on the back of the hands has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Impact of Madecassoside and 5 % Panthenol Cream in Post Photodynamic Therapy for Actinic Keratosis [NA]
A completed clinical trial evaluated the impact of applying Madecassoside and 5% panthenol cream after photodynamic therapy for actinic kera…
-
CLINICAL_TRIALS trial_result · 2024-04-19Clinical Trial Update: A Multi-Center Study to Evaluate the Efficacy and Safety of KX01 Ointment 1% on Actinic Keratosis on Face or Scalp [Phase 3]
A Phase 3 multicenter trial evaluating the efficacy and safety of KX01 Ointment 1% for actinic keratosis on the face or scalp has completed.
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: DUSA: Cyclic PDT for the Prevention of AK & NMSC in Solid Organ Transplant Recipients [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating cyclic photodynamic therapy (PDT) for prevention of actinic keratosis and non-mmelanoma skin…
-
FDA label_change · 2024-03-11FDA Approved: AMELUZ — Supplemental Application (Biofrontera Inc.)
FDA approved a supplemental application for AMELUZ (aminoLevulinic acid hydrochloride) from Biofrontera Inc., updating the labeling to refle…